We are pleased to announce the appointment of Dr. Anthony Daniels to our vol faculty effective April 1, 2024. Dr. Daniels is an ocular oncologist and vitreoretinal surgeon by training. He will be seeing ocular oncology patients in ophthalmology and serving the needs of ocular oncology patients throughout the Yale New Haven Health system. Simultaneously, he is serving as Therapeutic Area Head of Ocular Oncology at Aura Biosciences, where he is responsible for leading the ocular oncology program and driving future strategy.
Dr. Daniels previously was an Assistant Professor of Ophthalmology and Visual Sciences, Radiation Oncology, and Cancer Biology at Vanderbilt University School of Medicine in Nashville, TN. He served as Chief of the Division of Ocular Oncology and Pathology at Vanderbilt, and Program Director for the Ocular Oncology Fellowship program. He graduated summa cum laude from Princeton University, where he majored in molecular biology, and subsequently received a scholarship to pursue a master’s degree in public health policy from the London School of Economics. He then attended the University of Pennsylvania School of Medicine as the recipient of the institution’s most prestigious full scholarship. After his intern year at the Memorial Sloan Ketering Cancer Center, he completed both his ophthalmology residency and vitreoretinal fellowship at the Massachusetts's Eye and Ear Infirmary at Harvard Medical School, followed by additional tumor training at both the Mayo Clinic and at Memorial Sloan Ketering Cancer Center.
As an ocular oncologist and physician-scientist, his research has focused on drug discovery and development. His lab developed novel animal models of adult and pediatric eye cancers, and identified novel antineoplastic therapies, and his research techniques and models are now being used by centers around the world. In addition, he brings expertise in clinical trial design, with extensive experience designing and running clinical trials of all phases (I-IV).
Please join us in welcoming Dr. Daniels as the newest member of the Department of Ophthalmology and Visual Science.